THE ROLE THAT AN ANTI-TUMOR ANTIBODY PLAYS DURING PROGRESSIVE GROWTH OF P815Y IN SYNGENEIC HOST

被引：0
|
作者：
MANSON, LA
机构：
[1] WISTAR INST ANAT & BIOL, PHILADELPHIA, PA 19104 USA
[2] UNIV PENN, DEPT BIOL, PHILADELPHIA, PA 19104 USA
来源：
FASEB JOURNAL | 1988年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1836 / A1836
页数：1
相关论文
共 12 条
  • [1] DEVELOPMENT OF TUMOR-CELL RESISTANCE TO SYNGENEIC CELL-MEDIATED CYTOTOXICITY DURING GROWTH OF ASCITIC MASTOCYTOMA P815Y
    BIDDISON, WE
    PALMER, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (01) : 329 - 333
  • [2] THE ROLE OF ANTI-TUMOR ANTIBODY IN PROGRESSIVE TUMOR-GROWTH
    MANSON, LA
    [J]. TRANSPLANTATION PROCEEDINGS, 1984, 16 (02) : 524 - 527
  • [3] Tumoral P2Y2 receptor modulates tumor growth and host anti-tumor immune responses in a syngeneic murine model of oral cancer
    Forti, Kevin Munoz
    Woods, Lucas T.
    Jasmer, Kimberly J.
    Camden, Jean M.
    Weisman, Gary A.
    [J]. PURINERGIC SIGNALLING, 2024, 20 (04) : 359 - 370
  • [4] Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism
    Hawighorst, T
    Velasco, P
    Streit, M
    Hong, YK
    Kyriakides, TR
    Brown, LF
    Bornstein, P
    Detmar, M
    [J]. EMBO JOURNAL, 2001, 20 (11): : 2631 - 2640
  • [5] PD-L1 plays a B cell-intrinsic role in suppressing the antibody response and anti-tumor immunity.
    Cervantes, Christian
    Khan, Mustafa
    Fernandez, Maria
    Liu, Zexuan
    Hakeem, Zainab
    Viswanadhapalli, Suryavathi
    Gupta, Harshita B.
    Curiel, Tyler J.
    Yan, Hui
    Vadlamudi, Ratna
    Xu, Zhenming
    [J]. JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [6] VARIATIONS IN THE LEVEL OF HEMATOGENOUS ANTI-TUMOR IMMUNITY DURING PROGRESSIVE TUMOR-GROWTH AND SPONTANEOUS BLOOD-BORNE METASTATIC SPREAD
    PROCTOR, JW
    MASTROMATTEO, WP
    ANTOS, M
    HEDDERSON, ED
    [J]. ONCOLOGY, 1979, 36 (02) : 49 - 54
  • [7] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Naoto Kunimura
    Koichi Kitagawa
    Ryota Sako
    Keita Narikiyo
    Shoko Tominaga
    Diosdado S. Bautista
    Wei Xu
    Masato Fujisawa
    Toshiro Shirakawa
    [J]. Scientific Reports, 10
  • [8] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Kunimura, Naoto
    Kitagawa, Koichi
    Sako, Ryota
    Narikiyo, Keita
    Tominaga, Shoko
    Bautista, Diosdado S.
    Xu, Wei
    Fujisawa, Masato
    Shirakawa, Toshiro
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [9] The Anti-tumor T Cell Response Plays a Critical Role in the Therapeutic Effect of Dasatinib on C-kit Mutant Mastocytoma and can be Potentiated by Anti-OX40 Antibody
    Yang, Yan
    Liu, Chengwen
    Peng, Weiyi
    Mbofung, Rina M.
    Lizee, Gregory
    Overwijk, Willem W.
    Woodman, Scott E.
    Hwu, Patrick
    [J]. JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 775 - 775
  • [10] Long Non-Coding RNA LPP-AS2 Plays an Anti-Tumor Role in Thyroid Carcinoma by Regulating the miR-132-3p/OLFM1 Axis
    Zhang, Bowei
    Liu, Tong
    Gu, Yi
    Ren, Li
    Wang, Jinju
    Feng, Chao
    Song, Zhe
    [J]. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2023, 33 (05): : 73 - 86
12